Market Overview

Traders Shrug at JP Morgan's Ecopetrol Upgrade, Shares Modestly Lower

Related EC
Novartis' Erelzi, Biosimilar of Enbrel Approved In Europe
Novartis Cardiovascular Drug Positive, NSCLC Drug Approved

JP Morgan's Caio Carvalhal issued a note Tuesday boosting his investment rating on Ecopetrol (NYSE: EC) from Underweight to Neutral amid valuation and output growth.

Caio Carvalhal commented on Ecopetrol's "small premium to peers:" the stock currently trades at 9.2x his FY14 P/E estimate, notably above an 8x multiple for the company's international competitors.

Carvalhal is expecting Ecopetrol's production to grow 6.1 percent over 2012 to 2013; he sees 5 percent growth in production over 2014.

Shares of Ecopetrol are down about 0.5 percent on the NYSE despite the upgrade from Carvalhal.

Latest Ratings for EC

Dec 2016Deutsche BankUpgradesHoldBuy
Nov 2016Tudor PickeringUpgradesSellHold
Sep 2016Tudor PickeringUpgradesSellHold

View More Analyst Ratings for EC
View the Latest Analyst Ratings

Posted-In: Analyst Color Upgrades Analyst Ratings


Related Articles (EC)

View Comments and Join the Discussion!

Partner Center